S2Medical AB (publ) (FRA:S21)
Germany flag Germany · Delayed Price · Currency is EUR
0.0002
0.00 (0.00%)
Last updated: Jan 27, 2026, 8:16 AM CET

S2Medical AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
15.4714.687.726.1610.6327.53
Other Revenue
-0----0.44
15.4714.687.726.1610.6327.97
Revenue Growth (YoY)
40.76%90.03%25.39%-42.08%-61.98%399.50%
Cost of Revenue
1.840.772.690.993.5417.48
Gross Profit
13.6313.915.045.177.110.48
Selling, General & Admin
14.5714.9919.1431.5425.5423.06
Other Operating Expenses
1.11-7.22-0.57-0.61-0.11.18
Operating Expenses
16.959.0820.332.8526.9325.55
Operating Income
-3.324.83-15.26-27.69-19.84-15.06
Interest Expense
-0.04-0.02-7.44-1.77-0.24-0.07
Interest & Investment Income
000--0
Other Non Operating Income (Expenses)
-0.15-----
Pretax Income
-3.514.81-22.71-29.46-20.08-15.13
Net Income
-2.764.81-22.71-29.46-20.08-15.13
Net Income to Common
-2.764.81-22.71-29.46-20.08-15.13
Shares Outstanding (Basic)
841560121241512
Shares Outstanding (Diluted)
841560121241512
Shares Change (YoY)
241.73%360.86%411.02%60.30%26.41%3.86%
EPS (Basic)
-0.000.01-0.19-1.24-1.35-1.29
EPS (Diluted)
-0.000.01-0.19-1.24-1.35-1.29
Free Cash Flow
6.215.03-16.52-28.34-19.85-13.04
Free Cash Flow Per Share
0.010.01-0.14-1.19-1.34-1.11
Gross Margin
88.11%94.79%65.22%83.86%66.74%37.49%
Operating Margin
-21.46%32.89%-197.63%-449.53%-186.54%-53.85%
Profit Margin
-17.86%32.78%-294.00%-478.23%-188.83%-54.12%
Free Cash Flow Margin
40.12%34.28%-213.89%-460.08%-186.70%-46.64%
EBITDA
-2.665.52-14.14-26.37-18.73-14.14
EBITDA Margin
-17.21%37.61%-183.02%--176.11%-50.56%
D&A For EBITDA
0.660.691.131.321.110.92
EBIT
-3.324.83-15.26-27.69-19.84-15.06
EBIT Margin
-21.46%32.89%-197.63%--186.54%-53.85%
Revenue as Reported
14.2722.338.458.9311.528.7
Source: S&P Global Market Intelligence. Standard template. Financial Sources.